tryptophan has been researched along with Anti-MuSK Myasthenia Gravis in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kurashima, N; Ohkubo, A; Okado, T | 1 |
| Iimori, S; Itagaki, A; Kurashima, N; Maeda, T; Miyamoto, S; Mori, T; Naito, S; Ohkubo, A; Okado, T; Rai, T; Sakurasawa, T; Seshima, H; Sohara, E; Uchida, S; Yamamoto, H | 1 |
| Hammarström, L; Lefvert, AK; Pirskanen, R; Ramanujam, R; Yu, S; Zhao, Y | 1 |
| Jin, Q; Li, F; Li, H; Li, Y; Meng, F; Sun, C | 1 |
| Cheng, Y; Li, XH; Wang, SQ; Yang, L; Yu, YT | 1 |
| Casciani, CU; Cipriani, S; Costanzi, S; Fulignati, P; Passalacqua, S; Splendiani, G; Staffolani, E; Sturniolo, A | 1 |
| Hirata, N; Kuriyama, T; Yamawaki, N | 1 |
| Goto, F; Ishizeki, J; Kunimoto, F; Nishikawa, K | 1 |
| Capdevielle, C; Eymard, B; Gajdos, P; Garchon, HJ; Giraud, M; Jais, JP; Krumeich, S; Tranchant, C; Vandiedonck, C | 1 |
| Martin-Du Pan, RC; Wurtman, RJ | 1 |
| Heininger, K | 1 |
| Tamura, Y; Yamada, Y; Yamashita, Y; Yamawaki, N; Yoshida, M | 1 |
| Barbera, G; Casciani, CU; Costanzi, S; Fulignati, P; Passalacqua, S; Splendiani, G; Sturniolo, G | 1 |
| Carnegie, PR; Lennon, VA | 1 |
3 review(s) available for tryptophan and Anti-MuSK Myasthenia Gravis
| Article | Year |
|---|---|
Immusorba TR and PH.
Topics: Absorption; Acetylcholine; Arthritis, Rheumatoid; Autoantibodies; Biocompatible Materials; Clinical Trials as Topic; Equipment Design; Equipment Safety; Guillain-Barre Syndrome; Humans; Immunosorbent Techniques; Immunosorbents; Lupus Erythematosus, Systemic; Myasthenia Gravis; Phenylalanine; Sensitivity and Specificity; Tryptophan | 2003 |
[The role of nutrition in the synthesis of neurotransmitters and in cerebral functions: clinical implications].
Topics: Alzheimer Disease; Amino Acids; Choline; Choline O-Acetyltransferase; Diabetes Mellitus; Dopa Decarboxylase; Humans; Intellectual Disability; Memory; Myasthenia Gravis; Neurotransmitter Agents; Nutritional Physiological Phenomena; Serotonin; Tryptophan; Tyrosine | 1981 |
[In-vitro and in-vivo studies on the selective immunoadsorption treatment of neurological diseases].
Topics: Adolescent; Adult; Aged; Autoantibodies; Chronic Disease; Female; Humans; Immunosorbent Techniques; In Vitro Techniques; Male; Middle Aged; Myasthenia Gravis; Plasma Exchange; Polyneuropathies; Polyvinyl Alcohol; Receptors, Cholinergic; Tryptophan | 1993 |
1 trial(s) available for tryptophan and Anti-MuSK Myasthenia Gravis
| Article | Year |
|---|---|
Semi-selective immunoadsorption treatment in myasthenia gravis.
Topics: Adult; Autoantibodies; Female; Humans; Immunosorbent Techniques; Male; Middle Aged; Myasthenia Gravis; Plasma Exchange; Receptors, Cholinergic; Tryptophan | 1992 |
10 other study(ies) available for tryptophan and Anti-MuSK Myasthenia Gravis
| Article | Year |
|---|---|
Immunoadsorption With a Tryptophan-Immobilized Column Using Conventional and Selective Plasma Separators in the Treatment of Myasthenia Gravis.
Topics: Aged; Humans; Immunosorbent Techniques; Male; Myasthenia Gravis; Treatment Outcome; Tryptophan | 2018 |
Removal Characteristics of Immunoadsorption with the Tryptophan-Immobilized Column Using Conventional and Selective Plasma Separators in the Treatment of Myasthenia Gravis.
Topics: Autoantibodies; Cohort Studies; Female; Humans; Immunosorbent Techniques; Male; Middle Aged; Myasthenia Gravis; Plasma Exchange; Plasma Volume; Plasmapheresis; Receptors, Cholinergic; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Tryptophan | 2019 |
PTPN22 R620W promotes production of anti-AChR autoantibodies and IL-2 in myasthenia gravis.
Topics: Analysis of Variance; Arginine; Autoantibodies; Case-Control Studies; Female; Humans; Interleukin-2; Leukocytes, Mononuclear; Male; Myasthenia Gravis; Protein Tyrosine Phosphatase, Non-Receptor Type 22; Receptors, Cholinergic; Sweden; Tryptophan | 2008 |
Antigen-specific immunoadsorption of anti-acetylcholine receptor antibodies from sera of patients with myastenia gravis.
Topics: Animals; Autoantibodies; Blood Component Removal; Cellulose; Enzyme-Linked Immunosorbent Assay; Hematologic Tests; Humans; Immunodominant Epitopes; Immunosorbent Techniques; Microspheres; Myasthenia Gravis; Peptide Fragments; Rabbits; Receptors, Cholinergic; Tryptophan | 2010 |
Extracorporeal whole blood immuno-adsorption of passively transferred myasthenia gravis rabbits by cellulose-tryptophan column.
Topics: Adolescent; Adsorption; Adult; Animals; Biocompatible Materials; Cellulose; Child; Extracorporeal Circulation; Female; Humans; Immunoglobulin G; Immunoglobulins; Male; Middle Aged; Myasthenia Gravis; Neuromuscular Junction; Rabbits; Receptors, Nicotinic; Tryptophan; Young Adult | 2010 |
Plasmaperfusion on triptophan columns can improve the clinical outcome of patients affected with myasthenia gravis.
Topics: Acetylcholine; Adult; Autoantibodies; Biomarkers; Chromatography, Affinity; Female; Humans; Male; Middle Aged; Myasthenia Gravis; Perfusion; Plasmapheresis; Salvage Therapy; Treatment Outcome; Tryptophan | 2003 |
Postoperative myasthenic crisis successfully treated with immunoadsorption therapy.
Topics: Aged; Autoantibodies; Female; Heart Arrest; Humans; Immunosorbent Techniques; Myasthenia Gravis; Polyvinyl Alcohol; Postoperative Complications; Receptors, Cholinergic; Thymectomy; Treatment Outcome; Tryptophan | 2005 |
Association of the PTPN22*R620W polymorphism with autoimmune myasthenia gravis.
Topics: Adult; Aged; Alleles; Arginine; Confidence Intervals; Connectin; DNA Mutational Analysis; Female; Gene Frequency; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Muscle Proteins; Myasthenia Gravis; Odds Ratio; Polymorphism, Genetic; Protein Kinases; Protein Tyrosine Phosphatase, Non-Receptor Type 22; Protein Tyrosine Phosphatases; Tryptophan | 2006 |
Immusorba TR and Immusorba PH: basics of design and features of functions.
Topics: Acetylcholine; Adsorption; Antigen-Antibody Complex; Equipment Design; Gangliosides; Humans; Immunoglobulin G; Immunosorbent Techniques; Immunosorbents; Ligands; Myasthenia Gravis; Phenylalanine; Polyradiculoneuropathy; Polyvinyl Alcohol; Rheumatoid Factor; Tryptophan | 1998 |
Immunopharmacological disease: a break in tolerance to receptor sites.
Topics: Animals; Autoantibodies; Autoimmune Diseases; Cell Membrane; Chemoreceptor Cells; Disease Models, Animal; Encephalomyelitis; Humans; Multiple Sclerosis; Myasthenia Gravis; Tryptophan | 1971 |